GemVax&KAEL Co.Ltd Net Assets
GemVax&KAEL Co.Ltd net assets. Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has net assets worth ₩57.23 Billion KRW (≈ $38.78 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩158.87 Billion ≈ $107.67 Million USD) and total liabilities (₩101.65 Billion ≈ $68.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore GemVax&KAEL Co.Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩57.23 Billion |
| % of Total Assets | 36.02% |
| Annual Growth Rate | 1.27% |
| 5-Year Change | -62.84% |
| 10-Year Change | 7.12% |
| Growth Volatility | 41.89 |
Net Assets of GemVax&KAEL Co.Ltd (2010–2025)
Net assets of GemVax&KAEL Co.Ltd from 2010 to 2025. This chart illustrates how GemVax&KAEL Co.Ltd's net assets have evolved over time, based on quarterly financial data. See how leveraged is GemVax&KAEL Co.Ltd's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for GemVax&KAEL Co.Ltd (2010–2025)
The table below shows the annual net assets of GemVax&KAEL Co.Ltd from 2010 to 2025. For live market cap and overall valuation, see market value of GemVax&KAEL Co.Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩57.23 Billion ≈ $38.78 Million |
+97.30% |
| 2024-12-31 | ₩29.01 Billion ≈ $19.66 Million |
-73.15% |
| 2023-12-31 | ₩108.02 Billion ≈ $73.20 Million |
-19.60% |
| 2022-12-31 | ₩134.35 Billion ≈ $91.05 Million |
-12.75% |
| 2021-12-31 | ₩153.99 Billion ≈ $104.35 Million |
+13.89% |
| 2020-12-31 | ₩135.21 Billion ≈ $91.63 Million |
+42.39% |
| 2019-12-31 | ₩94.95 Billion ≈ $64.35 Million |
-16.57% |
| 2018-12-31 | ₩113.81 Billion ≈ $77.13 Million |
+70.01% |
| 2017-12-31 | ₩66.94 Billion ≈ $45.37 Million |
+25.30% |
| 2016-12-31 | ₩53.43 Billion ≈ $36.21 Million |
+12.00% |
| 2015-12-31 | ₩47.70 Billion ≈ $32.33 Million |
+8.58% |
| 2014-12-31 | ₩43.94 Billion ≈ $29.77 Million |
-34.00% |
| 2013-12-31 | ₩66.57 Billion ≈ $45.11 Million |
+8.62% |
| 2012-12-31 | ₩61.29 Billion ≈ $41.53 Million |
-17.04% |
| 2011-12-31 | ₩73.88 Billion ≈ $50.07 Million |
+56.01% |
| 2010-12-31 | ₩47.35 Billion ≈ $32.09 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GemVax&KAEL Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2979.3% over the analyzed period, potentially due to dividend distributions or operating losses.
GemVax&KAEL Co.Ltd Net Assets Breakdown (December 2025)
GemVax&KAEL Co.Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩135.65 Billion | 237.03% |
| Total Equity | ₩57.23 Billion | 100.00% |
GemVax&KAEL Co.Ltd Competitors by Market Cap
The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHTC Helon Co Ltd
SHE:000677
|
$209.87 Million |
|
The Orissa Minerals Development Company Limited
NSE:ORISSAMINE
|
$210.00 Million |
|
Shanghai Mechanical & Electrical Industry Co Ltd B
SHG:900925
|
$210.03 Million |
|
Mold-Tek Packaging Limited
NSE:MOLDTKPAC
|
$210.22 Million |
|
Berkeley Energia Ltd
AU:BKY
|
$209.76 Million |
|
Medallion Metals Ltd
AU:MM8
|
$209.74 Million |
|
AC Immune Ltd
NASDAQ:ACIU
|
$209.65 Million |
|
Hester Biosciences Limited
NSE:HESTERBIO
|
$209.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GemVax&KAEL Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 29,005,833,960 to 57,228,866,330, a change of 28,223,032,370 (97.3%).
- Net loss of 11,336,638,390 reduced equity.
- Other factors increased equity by 39,559,670,760.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-11.34 Billion | -19.81% |
| Other Changes | ₩39.56 Billion | +69.13% |
| Total Change | ₩- | 97.30% |
Book Value vs Market Value Analysis
This analysis compares GemVax&KAEL Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.38x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.97x to 6.38x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1746.59 | ₩8680.00 | x |
| 2017-12-31 | ₩2189.03 | ₩8680.00 | x |
| 2018-12-31 | ₩3239.42 | ₩8680.00 | x |
| 2019-12-31 | ₩2475.53 | ₩8680.00 | x |
| 2020-12-31 | ₩3425.48 | ₩8680.00 | x |
| 2021-12-31 | ₩3880.11 | ₩8680.00 | x |
| 2022-12-31 | ₩3420.24 | ₩8680.00 | x |
| 2023-12-31 | ₩2740.38 | ₩8680.00 | x |
| 2024-12-31 | ₩731.00 | ₩8680.00 | x |
| 2025-12-31 | ₩1360.13 | ₩8680.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GemVax&KAEL Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -19.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.90%
- • Asset Turnover: 0.51x
- • Equity Multiplier: 2.78x
- Recent ROE (-19.81%) is above the historical average (-62.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 2.89% | 1.89% | 0.46x | 3.34x | ₩-3.09 Billion |
| 2014 | -300.81% | -31.66% | 0.95x | 9.99x | ₩-33.06 Billion |
| 2015 | -5.14% | -3.27% | 0.42x | 3.78x | ₩-7.22 Billion |
| 2016 | -39.21% | -73.75% | 0.15x | 3.55x | ₩-26.29 Billion |
| 2017 | -18.33% | -25.63% | 0.30x | 2.40x | ₩-18.97 Billion |
| 2018 | -9.41% | -22.66% | 0.27x | 1.52x | ₩-22.09 Billion |
| 2019 | -97.00% | -215.88% | 0.26x | 1.72x | ₩-101.60 Billion |
| 2020 | 1.21% | 2.49% | 0.41x | 1.17x | ₩-11.89 Billion |
| 2021 | 7.83% | 19.97% | 0.35x | 1.12x | ₩-3.34 Billion |
| 2022 | -14.59% | -25.86% | 0.50x | 1.12x | ₩-33.04 Billion |
| 2023 | -25.16% | -37.64% | 0.53x | 1.25x | ₩-37.98 Billion |
| 2024 | -300.69% | -139.12% | 0.42x | 5.20x | ₩-90.12 Billion |
| 2025 | -19.81% | -13.90% | 0.51x | 2.78x | ₩-17.06 Billion |
Industry Comparison
This section compares GemVax&KAEL Co.Ltd's net assets metrics with peer companies in the Semiconductors & Semiconductor Equipment industry.
Industry Context
- Industry: Semiconductors & Semiconductor Equipment
- Average net assets among peers: $110,934,670,613
- Average return on equity (ROE) among peers: 1.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GemVax&KAEL Co.Ltd (082270) | ₩57.23 Billion | 2.89% | 1.78x | $209.84 Million |
| PSK HOLDINGS Inc (031980) | $251.54 Billion | 18.53% | 0.22x | $677.07 Million |
| Fidelix Co. Ltd (032580) | $27.95 Billion | 10.94% | 1.26x | $109.85 Million |
| Cloud Air Co.Ltd (036170) | $118.67 Billion | 6.91% | 0.02x | $51.39 Million |
| UNISEM Co. Ltd (036200) | $63.88 Billion | 5.09% | 0.47x | $167.90 Million |
| JUSUNG ENGINEERING Co. Ltd (036930) | $168.08 Billion | 1.22% | 1.19x | $5.49 Billion |
| Lumens Co. Ltd (038060) | $179.06 Billion | -17.75% | 0.86x | $24.66 Million |
| iA Inc (038880) | $59.39 Billion | 2.85% | 0.84x | $460.77 Million |
| meerecompany Incorporated (049950) | $96.75 Billion | -14.96% | 0.26x | $45.46 Million |
| I&C Technology Co. Ltd (052860) | $80.36 Billion | 0.00% | 0.06x | $75.82 Million |
| KMH Hitech Co. Ltd (052900) | $63.65 Billion | 3.50% | 0.19x | $32.07 Million |
About GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more